Clinical Trials › NCT06428006
RecruitingPhase 2
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
Sponsored by University of Kansas Medical Center
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 70
Target enrollment
1
U.S. states
Jul 2024
Start date
May 2027
Expected completion
Interventions / Treatments
Cognitive behavioral therapy for insomniaSleep and lifestyle education
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Kansas1 site
Kansas City
MS centers in Kansas
Compare treatment centers near a trial site by center type, providers and trials.
View Kansas centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.